Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01057355 | Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms | withdrawn | Phase 1 | 0 | Mayo ClinicOTHER | 0 | Sep 19, 2014 | clinicaltrials |
| NCT01741597 | Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | May 30, 2014 | clinicaltrials |
| NCT01600807 |
| OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas |
| withdrawn |
| Phase 1 / Phase 2 |
| 0 |
| Dana-Farber Cancer InstituteOTHER |
| 1 |
| Jun 26, 2013 |
| clinicaltrials |
| NCT01017822 | Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Radiation Therapy Oncology GroupNETWORK | 0 | Jun 24, 2013 | clinicaltrials |
| NCT00027521 | Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer | withdrawn | Phase 1 | 0 | Ichor Medical Systems IncorporatedINDUSTRY | 0 | Sep 19, 2012 | clinicaltrials |
| NCT00025532 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Sep 14, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Sep 19, 2014source: clinicaltrials